Press Releases
View printer-friendly version << BackMarch 27, 2015 at 2:36 PM EDT
Flamel Technologies Announces Positive Results of a First-in-Man Clinical Trial with LiquiTime® Guaifenesin
Flamel Technologies Announces Positive Results of a First-in-Man Clinical Trial with LiquiTime® Guaifenesin